- Home
- App Analytics
- OCS-Plus
OCS-Plus app analytics for December 23
OCS-Plus
- University of Oxford
- Apple App Store
- Free
- Medical
OCS-Plus provides health professionals with a brief cognitive assessment focussed on memory and executive attention. OCS-Plus was developed by the Translational Neuropsychology Research Group at the University of Oxford. The tool has been standardised, normed and validated (Demeyere et al 2021). The tool is currently undergoing further research for validity of use in specific clinical groups.
The tool is not for self-assessment. Instead, a health professional assessor administers the screen to respondents to investigate domain-general cognitive impairments, with a specific focus on memory and executive attention. The tool contains multiple easy to administer tests and instructions are provided for each test. Normative data is provided for three age groups : under 60, between 60 and 70, and older than 70 and respondent performance is automatically compared to established normative cut offs.
In order to activate the app for use, registration is required. There is no cost for the standard app version where data is not uploaded. Where data upload is required, an administration fee, as well as a collaboration agreement and datasharing agreement is required to be put in place.
Store Rank
The Store Rank is based on multiple parameters set by Google and Apple.
All Categories in
United States--
Medical in
United States--
Create an account to see avg.monthly downloadsContact us
OCS-Plus Ranking Stats Over Time
Similarweb's Usage Rank & Apple App Store Rank for OCS-Plus
Rank
No Data Available
OCS-Plus Ranking by Country
Counties in which OCS-Plus has the highest ranking in its main categories
No Data to Display
Top Competitors & Alternative Apps
Apps with a high probability of being used by the same users, from the same store.
IGNITE App
Jonathan Rohrer
Apollo - Cognitive Testing
ki elements GmbH
Orpington Prognostic Scale
DOCTOT
Reading Therapy
Tactus Therapy Solutions Ltd
OCS-Plus VS.
December 23, 2024